Telomerase activity and patient survival after surgery for gastric and oesophageal cancer

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 8, 2001, Pages 903-908

  Usselmann, Bernhard ^a   Newbold, Mark ^b   Morris, Alan G ^a   Nwokolo, Chuka U ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Oesophageal neoplasms; Stomach neoplasms; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; CANCER CELL; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS CANCER; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; PATHOGENESIS; PHENOTYPE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034884594     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200108000-00005     Document Type: Article

References (25)

1. World Health Organization. The World Health Report: Health Systems, Improving Performance. Geneva; 2000.
2. Spechler SJ. Barrett’s oesophagus: an overrated risk factor. Gastroenterology 2000; 119: 587-589.
3. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 2000; 340: 825-831.
4. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N. et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1132.
5. Morales TG. Adenocarcinoma of the gastric cardia. Dig Dis Sci 1997; 15: 346-356.
6. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-529.
7. Nugent CI, Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev 1998; 12: 1073-1085.
8. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A. et al. Inhibition of telomerase limits the growth of human cancer cells. Nature Med 1999; 5: 1164-1170.
9. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
10. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997; 25: 2595-2597.
11. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-791.
12. Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS. et al. Induction of cytotoxic T-cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nature Med 2000; 6: 1011-1017.
13. Kameshima H, Yagihashi A, Yajima T, Kobayashi D, Denno R, Hirata K. et al. Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues. World J Surg 2000; 24: 1243-1249.
14. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y. et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-3262.
15. Sachs L. Applied Statistics: a Handbook of Techniques. New York: Springer Verlag; 1982. pp. 317-318.
16. Ahn M-J, Noh YH, Lee YS, Lee JH, Chung TJ, Kim IS. et al. Telomerase activity and its clinicopathological significance in gastric cancer. Eur J Cancer 1997; 33: 1309-1313.
17. Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, Ide T. et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245-1251.
18. Okusa Y, Ichikura T, Mochizuki H, Shinomiya N. Clinical significance of telomerase activity in biopsy specimens of gastric cancer. J Clin Gastroenterol 2000; 30: 61-63.
19. Morales CP, Lee EL, Shay JW. In situ hybridization for the detection of telomerase RNA in the progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer 1998; 83: 652-659.
20. Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM. et al. Telomerase reverse transcriptase expression is increased early in the Barrett’s metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 2000; 4: 135-142.
21. Nakamura Y, Tahara E, Tahara H, Yasui W, Tahara E. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog 1999; 26: 312-320.
22. Gollahon LS, Holt SE. Alternative methods of extracting telomerase activity from human tumor samples. Cancer Lett 2000; 159: 141-149.
23. Heine B, Hummel M, Demel G, Stein H. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridisation. J Pathol 1998; 185: 139-144.
24. Kyo S, Takamura M, Tanaka M, Kanaya T, Inoue M. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer 1998; 79: 66-70.
25. Uehara H, Nardone G, Nazarenko I, Hohman RJ. Detection of telomerase activity utilizing energy transfer primers: comparison with gel- and ELISA-based detection. Biotechniques 1999; 26: 552-558.